Aanox Ltd. London Research Laboratory

AANOX provides a unified evidence layer for regulated healthcare, meticulously tracking product development from initial university hypothesis to final pharmacy shelf. Key features include: • Comprehensive tracking of product development lifecycle • Improved success rates for clinical trials • Integration of molecular discovery and causal safety intelligence • Ensuring GxP compliance and auditable records This platform serves as a critical infrastructure for the pharmaceutical and clinical science sectors. It combines a biology-aware storage engine, a causal engine designed for verifiable identification, and a robust compliance layer. This integrated approach ensures that every step in the medicine development process is backed by immutable, high-assurance data. AANOX is built to accelerate biomedical breakthroughs by transforming how research becomes reproducible and how findings are verified. It addresses the challenge of unsolved diseases by applying fundamental biological building blocks to complex human health challenges, producing deterministic and verifiable results. This system is ideal for pharmaceutical companies, clinical research organizations, and regulatory bodies seeking to enhance the reliability and efficiency of drug development and compliance.